| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A germinal center–associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL
|
Miyawaki, Kohta
|
|
|
6 |
7 |
p. 2388-2402
|
artikel
|
| 2 |
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
|
Alderuccio, Juan Pablo
|
|
|
6 |
7 |
p. 2035-2044
|
artikel
|
| 3 |
Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice
|
Pletinckx, Katrien
|
|
|
6 |
7 |
p. 2069-2080
|
artikel
|
| 4 |
A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD
|
Bury, Loredana
|
|
|
6 |
7 |
p. 2236-2246
|
artikel
|
| 5 |
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes
|
Zeidan, Amer M.
|
|
|
6 |
7 |
p. 2207-2218
|
artikel
|
| 6 |
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML
|
Zeidan, Amer M.
|
|
|
6 |
7 |
p. 2219-2229
|
artikel
|
| 7 |
A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins
|
Bang, Benedicte
|
|
|
6 |
7 |
p. 2275-2289
|
artikel
|
| 8 |
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
|
Pettini, Elena
|
|
|
6 |
7 |
p. 2247-2249
|
artikel
|
| 9 |
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
|
Akin, Serkan
|
|
|
6 |
7 |
p. 2267-2274
|
artikel
|
| 10 |
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
|
Holland, Elizabeth M.
|
|
|
6 |
7 |
p. 2167-2182
|
artikel
|
| 11 |
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia
|
Tahri, Sabrin
|
|
|
6 |
7 |
p. 2230-2235
|
artikel
|
| 12 |
Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors
|
Iyer, Aishwarya
|
|
|
6 |
7 |
p. 2334-2345
|
artikel
|
| 13 |
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones
|
Houtsma, Roos
|
|
|
6 |
7 |
p. 2129-2143
|
artikel
|
| 14 |
Coping strategies in patients with acute myeloid leukemia
|
Amonoo, Hermioni L.
|
|
|
6 |
7 |
p. 2435-2442
|
artikel
|
| 15 |
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
|
Busca, Alessandro
|
|
|
6 |
7 |
p. 2427-2433
|
artikel
|
| 16 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements
|
Frauenfeld, Leonie
|
|
|
6 |
7 |
p. 2361-2372
|
artikel
|
| 17 |
Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
|
Barosi, Giovanni
|
|
|
6 |
7 |
p. 2331-2333
|
artikel
|
| 18 |
Editorial Board
|
|
|
|
6 |
7 |
p. i
|
artikel
|
| 19 |
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
|
Dekker, Linde
|
|
|
6 |
7 |
p. 1969-1976
|
artikel
|
| 20 |
Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation
|
Xu, Jane Jialu
|
|
|
6 |
7 |
p. 2092-2106
|
artikel
|
| 21 |
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses
|
Knudsen, Trine Alma
|
|
|
6 |
7 |
p. 2107-2119
|
artikel
|
| 22 |
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
|
Ho, Vincent T.
|
|
|
6 |
7 |
p. 2183-2194
|
artikel
|
| 23 |
G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1
|
Downes, Kate
|
|
|
6 |
7 |
p. 2319-2330
|
artikel
|
| 24 |
Hematologic malignancies magnify the effect of body mass index on insulin resistance in cancer survivors
|
Sahinoz, Melis
|
|
|
6 |
7 |
p. 1981-1990
|
artikel
|
| 25 |
Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation
|
Shahin, Tala
|
|
|
6 |
7 |
p. 2444-2451
|
artikel
|
| 26 |
Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis
|
Teh, Joanne S.K.
|
|
|
6 |
7 |
p. 2014-2034
|
artikel
|
| 27 |
Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients
|
Mead, Monica
|
|
|
6 |
7 |
p. 2120-2128
|
artikel
|
| 28 |
Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
|
Thiruvengadam, Swetha Kambhampati
|
|
|
6 |
7 |
p. 2045-2054
|
artikel
|
| 29 |
Inflammasome activation in neutrophils of patients with severe COVID-19
|
Aymonnier, Karen
|
|
|
6 |
7 |
p. 2001-2013
|
artikel
|
| 30 |
IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma
|
Elfrink, Suraya
|
|
|
6 |
7 |
p. 2254-2266
|
artikel
|
| 31 |
Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans
|
Brandl, Andreas
|
|
|
6 |
7 |
p. 2195-2206
|
artikel
|
| 32 |
Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
|
Xiang, Jingyu
|
|
|
6 |
7 |
p. 1991-2000
|
artikel
|
| 33 |
Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice
|
Dorrance, Adrienne M.
|
|
|
6 |
7 |
p. 2403-2408
|
artikel
|
| 34 |
Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib
|
Smith, Catherine C.
|
|
|
6 |
7 |
p. 2144-2155
|
artikel
|
| 35 |
Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand
|
Stoller, Michelle L.
|
|
|
6 |
7 |
p. 2303-2308
|
artikel
|
| 36 |
Neutrophil transit time and localization within the megakaryocyte define morphologically distinct forms of emperipolesis
|
Huang, Frank Y.
|
|
|
6 |
7 |
p. 2081-2091
|
artikel
|
| 37 |
NPM1 gene mutations can be confidently identified in blood DNA months before de novo AML onset
|
Quiros, Pedro M.
|
|
|
6 |
7 |
p. 2409-2413
|
artikel
|
| 38 |
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy
|
Fabrizio, Vanessa A.
|
|
|
6 |
7 |
p. 1961-1968
|
artikel
|
| 39 |
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation
|
Hough, Rachael
|
|
|
6 |
7 |
p. 2414-2426
|
artikel
|
| 40 |
Samra B, Khoury JD, Morita K, et al. Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse. Blood Adv. 2021;5(20):3913-3918.
|
|
|
|
6 |
7 |
p. 2452
|
artikel
|
| 41 |
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia
|
Appelbaum, Jacob
|
|
|
6 |
7 |
p. 2250-2253
|
artikel
|
| 42 |
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy
|
Juluri, Krishna R.
|
|
|
6 |
7 |
p. 2055-2068
|
artikel
|
| 43 |
SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia
|
Brown, Lauren M.
|
|
|
6 |
7 |
p. 2373-2387
|
artikel
|
| 44 |
Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20–opsonized B cells to neutrophil killing
|
van Rees, Dieke J.
|
|
|
6 |
7 |
p. 2156-2166
|
artikel
|
| 45 |
Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting
|
Swarray-Deen, Alim
|
|
|
6 |
7 |
p. 1977-1980
|
artikel
|
| 46 |
Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models
|
Wu, Chi-Heng
|
|
|
6 |
7 |
p. 2290-2302
|
artikel
|
| 47 |
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
|
Metafuni, Elisabetta
|
|
|
6 |
7 |
p. 2309-2318
|
artikel
|
| 48 |
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
|
Daenthanasanmak, Anusara
|
|
|
6 |
7 |
p. 2346-2360
|
artikel
|
| 49 |
Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092.
|
|
|
|
6 |
7 |
p. 2434
|
artikel
|
| 50 |
Xu S, Wang S, Xing S, et al. KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2. Blood Adv. 2021;5(17):3241-3253.
|
|
|
|
6 |
7 |
p. 2443
|
artikel
|
Tijdschrift beschrijving